Nivolumab/pembrolizumabPneumonia: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1846卷 / 1期

关键词：

D O I：

10.1007/s40278-021-92491-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：243 / 243

相关论文

共 50 条

[31] Nivolumab/relatlimabVarious toxicities: case report
Reactions Weekly, 2024, 2021 (1) : 429 - 429
[32] Nivolumab/pembrolizumabThrombocytopenia and anaphylaxis: case report
Reactions Weekly, 2018, 1683 (1) : 525 - 525
[33] Nivolumab/prednisoneCytomegalovirus enterocolitis: case report
Reactions Weekly, 2022, 1893 (1) : 267 - 267
[34] Nivolumab/sunitinibColitis and diarrhoea: case report
Reactions Weekly, 2020, 1795 (1) : 211 - 211
[35] Nivolumab/lomustineAplastic anaemia: case report
Reactions Weekly, 2019, 1734 (1) : 378 - 378
[36] Ipilimumab/nivolumab/pembrolizumabPneumonitis: case report
Reactions Weekly, 2018, 1713 (1) : 204 - 204
[37] Nivolumab/prednisoloneVarious toxicities: case report
Reactions Weekly, 2022, 1893 (1) : 266 - 266
[38] Nivolumab/PembrolizumabBullous pemphigoid: case report
Reactions Weekly, 2017, 1671 (1) : 312 - 312
[39] Nivolumab/sunitinibVarious toxicities: case report
Reactions Weekly, 2022, 1887 (1) : 536 - 536
[40] Nivolumab/prednisoloneVarious toxicities: case report
Reactions Weekly, 2019, 1752 (1) : 299 - 299

← 1 2 3 4 5 →